Jennifer Feng
Overview
Jennifer is very responsive and willing to consider all aspects of the business, providing practical and well-rounded solutions. She possesses strong technical knowledge and commercial awareness, and has the ability to communicate and explain concepts to clients in a clear and concise manner.” - Chambers Greater China
Jennifer Feng co-heads the Asia investment funds practice of Kirkland & Ellis. She advises international, regional and country-focused private investment fund sponsors spanning Greater China, Japan, Korea, Australia, India, Singapore and South East Asia in relation to the structuring and establishment of private investment funds that invest across all major alternative investment strategies, including private equity buyout, growth, venture capital, credit and real assets.
Jennifer also advises on a broad range of other transactions related to investment funds, including secondary transactions, fund restructurings, continuation vehicles, preferred equity arrangements, co-investment arrangements, separate managed accounts as well as sponsor commitment and carried interest schemes.
Jennifer has represented, among others, Ark & Partners, Centurium Capital, Centroid Investment Partners, CD Capital, Creador, Dayone Capital, Dignari Capital Partners, EMR Capital, Genesis Capital, GL Capital, Hanwha Asset Management, Japan Growth Investment Alliance (JGIA), KKR, L Catterton, Lilly Asia Ventures, Panacea Ventures, Patience Capital Group, Potentia, Praxis Capital Partners, Premier Partners and Tower Capital Asia.
In 2026, Chambers Greater China named Jennifer as an “Up and Coming” lawyer in private equity funds, while The Legal 500 named her a “Next Generation Partner” in investment funds. In 2025–2026, Chambers Asia-Pacific named Jennifer as a “Notable Practitioner” in private equity funds. In 2023–2025, IFLR1000 named Jennifer as a “Rising Star Partner” in private equity funds.
In addition to her client work, Jennifer serves on a number of internal administrative committees, including the Asia Billings & Collections Committee, the Asia Associate Review Committee and the Asia Operations Committee.
Experience
Representative Matters
Ark & Partners, a Korea based growth equity firm, in the formation of its first fund (US$150 million)
Archer Capital, an independent Australian private equity firm, in the formation of Archer Capital Fund 5 (A$1.5 billion) and Archer Capital Growth Fund 2 (A$300 million)
C-Bridge Capital in the formation of its fourth flagship healthcare buyout fund
CD Capital, a specialist natural resources and mining private equity manager, in the formation of its third private equity fund (c. US$355 million)
Centurium Capital in the formation of Centurium Capital Partners 2018 (US$2 billion)
Creador, an independent South East Asia private equity firm, in the formation of its Fund VI ($930 million); Fund V (US$671 million); Fund IV (US$650 million); Fund III (c. US$415 million)
Crescent Point Group, a South East Asia investment firm specializing in special situations investments, in the formation of its (i) consumer and special opportunities private sleeve fund (US$198 million) and (ii) consumer and special opportunities institutional sleeve fund (US$165 million)
Dayone Capital in the formation of its first USD fund of over US$630 million
EMR Capital, a specialist mining private equity manager, in the formation of its second private equity fund (c. US$860 million)
Fountainvest Capital Partners in the joint venture and joint venture fund with Mars Inc. (US$1 billion)
Genesis Capital, a China based private equity firm, in the formation of its third fund (US$630 million)
GL Capital in its proposed privatization of SciClone Pharmaceuticals (Holdings) Limited (HKSE: 6600), a company incorporated in the Cayman Islands and listed on the Hong Kong Stock Exchange
GL Capital, a China based healthcare sponsor, in the formation of its fifth flagship fund (US$482 million)
Hammer Capital in its investment fund structure in respect of an announced take-private transaction by an investor consortium (of which Hammer Capital is a member, the other member being Tencent Holdings (HKSE: 700)), to acquire Bitauto Holdings Limited (NYSE: BITA) at US$1.1 billion, and the consequential mandatory general offer for the shares of Yixin Group Limited (HKSE: 2858) valued at US$1.6 billion pursuant to the chain principle under the Hong Kong Takeovers Code
Hidden Hill Capital in the formation of its Fund I (US$600 million) and Foundation Fund (US$500 million)
Hosen Capital in the formation of its Fund III (US$800 million)
Japan Growth Investment Alliance (JGIA), a Japan mid-market private equity sponsor, in the formation of its third private equity fund (JPY 65 billion)
L Catterton in its GP-led secondary transaction and formation of L Catterton Asia 3 Continuation Fund. This transaction was named Secondaries Deal of the Year in Asia by The PEI Awards 2022.
L Catterton in the formation of L Catterton Asia 3 (US$1.45 billion) and L Capital Asia 2 (c. US$1 billion)
L Catterton in its US$250 million investment in Jio Platforms, a next-generation Indian technology company and subsidiary of Reliance Industries. This transaction was named TMT Deal of the Year by The Asia Legal Awards 2021
LAV in the formation of LAV Fund VII, Fund VI, Fund V, Fund IV, Fund III of over US$4.2 billion
Ocean Link in the formation of its second USD fund, Ocean Link Fund II (US$580 million)
Olympus Capital Asia in the $450 million restructuring of Olympus Capital Asia's third fund
Orchid Asia, an independent Chinese private equity firm, in the formation of its seventh private equity fund (c. US$1.3 billion) and its sixth private equity fund (c. US$920 million)
Pacific Road Capital Management, a specialist mining private equity firm, in the formation of Pacific Road Resources Fund II (US$475 million)
PAG in the formation of PAG Asia III (US$6 billion)
Panacea Venture in the formation of its Fund I (US$180 million); Fund II (over US$276 million)
Patience Capital Group in the joint venture and related co-investment funds in the acquisition of Tokyu Plaza Ginza (US$1 billion)
Saratoga Capital, an independent Indonesian private equity firm, in the formation of Saratoga Asia III (US$600 million)
The Growth Fund, an independent Australian private equity firm, in the formation of The Growth Fund 3 (A$450 million)
Vision Knight Capital, an independent Chinese private equity firm, in the formation of its second China private equity fund (US$550 million)
Prior Experience
- Associate, 2015–2017
-
Trainee Solicitor, 2010–2012
- Associate, 2012–2015
More
Recognition
“Up and Coming”, Investment Funds: Private Equity – China, Chambers Greater China (2026)
“Next Generation Partner”, Investment Funds – The Legal 500 (2026)
“Notable Practitioner”, Investment Funds: Private Equity – Chambers Asia-Pacific (2025)
“Rising Star Partner”, Private Equity Funds – Hong Kong, IFLR1000 (2023–2025)
“Expert Guides Rising Star”, Investment Funds – Hong Kong, IFLR1000 (2022)
Credentials
Admissions & Qualifications
- 2020, Hong Kong, Solicitor
- 2012, Admitted to practice as a Solicitor of England and Wales
Languages
- English
- Cantonese
- Mandarin
Education
- College of Law, LondonLPCwith Distinction2010
- University of Nottingham2009